Real net profit fell 105.4% — nominal growth cannot offset inflation
Real revenue fell 95.2% — insufficient pricing power
Reel ROE %-2.1 — enflasyon düzeltmesinden sonra zarar
Yıllık %31 enflasyon altında eziliyor — reel küçülme
| Quarter |
CPI YoY |
Deflator |
Nominal Net Profit |
Real Net Profit |
Real Growth |
Nominal Revenue |
Real Revenue |
Reel ROE |
| 2026/3 |
%31 |
×1.07 |
₺-22M |
₺-23M |
%-105.4 |
₺47M |
₺51M |
%-2.1 |
| 2025/12 |
%31 |
×1.18 |
₺365M |
₺430M |
%+225.2 |
₺901M |
₺1.1B |
%39.0 |
| 2025/6 |
%35 |
×1.32 |
₺-100M |
₺-132M |
%-128.1 |
₺65M |
₺86M |
%-14.8 |
| 2025/3 |
%38 |
×1.40 |
₺-337M |
₺-472M |
%-249.3 |
₺-37M |
₺-52M |
%-64.3 |
| 2024/12 |
%44 |
×1.54 |
₺205M |
₺316M |
%-24.2 |
₺205M |
₺315M |
%29.3 |
| 2024/9 |
%49 |
×1.64 |
₺-254M |
₺-416M |
%-140.1 |
— |
— |
— |
| 2024/6 |
%72 |
×1.78 |
₺-582M |
₺-1.0B |
— |
— |
— |
— |
Fundamental & Technical Analysis
TRAMA-99 Trend — Strong Downtrend
Price (2.42), TRAMA-99 line's %24.2 below. Significant downtrend. TRAMA line acts as strong technical resistance.
Price:: 2.42
TRAMA: 3.1943
Difference: %-24.2
Net Profit Margin
%-45.8
Net profit margin %-45.8 — loss period. Compared to previous quarter -86.3 point decrease.
ROE – Özkaynak Getirisi (TTM)
%8.8
ROE %8.8 — low return on equity.
EBITDA Margin
%-43.1
EBITDA margin %-43.1 — operational loss.
Free Cash Flow Margin (TTM)
%15.8
TTM Free Cash Flow is %15.8'i. Strong FCF generation — profit quality is high.
P/E Ratio
8.5x
Sector: 15.3x
F/K 8.5x — sector median's (15.3x) %44 below. Attractive for value investing.
P/B Ratio
0.68x
Sector: 1.09x
PD/DD 0.68x — sector median's (1.09x) çok below. Defter değerine göre undervalued.
Current Ratio
4.46x
Current ratio 4.46x — current assets are 2x short-term liabilities. Very healthy liquidity.
Debt / Equity
0.00x
Low leverage — majority of assets financed by equity.
Interest Coverage
-33.3x
Interest coverage -33.3x — critical level. Risk of difficulty in interest payments.
Revenue Growth (YoY)
%+226.7
Revenue YoY %226.7 grew (2026/3) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY)
%+93.6
Loss %93.6 decreased — improvement continues.
Score Explanations
Lothien Robustness
72/100
Very strong robustness score (72/100). Damodaran valuation, Dalio risk analysis and balance sheet quality criteria are largely met.
Very Strong
Potential
+29.8%
Plus %29.8 expected value (3.18) vs current price comparison. 2/4 valuation models give 'BUY' signal. Model confidence %56.
Components: PE target: 3.38 | P/B target: 3.96
Damodaran Valuation
49/100
Low Damodaran score (49/100). DCF analysis does not support current price. Minusk/sorunlu: ROIC banka/finans için tanımsız — mevduat/prim fonlaması borç değil hammaddedir; değerleme öz-sermaye (P/DD) tabanlı yapılır; DCF hesaplanamadı (faaliyet kârı veya nakit akışı eksik).
Moderate
Dalio Risk Analysis
81/100
Low debt risk (81/100). Interest coverage ratio -33.3x — weak, fragile.
Leverage: 50/100 | Debt Service: 100/100 | Quality: 43/100
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
3/9
Weak Piotroski (3/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); gross profit data missing → margin comparison unavailable (C8)
Weak
Graham Intrinsic Value
—
Company is loss-making (EPS = -0.0824 TL) — Graham formula requires positive earnings
⚖️ Sector Comparison
Sector mediannın %44 below — cheap
Compared to sector %38 cheaper (by book value)
TTM net profit margin %36.8
Analyst Views and Target Price — external source
Bu bölümdeki dereceler ve hedef fiyat, aracı kurum analistlerinin kendi
beyanlarıdır; Lothien'in görüşü değildir ve doğrulanmamıştır.
This is not investment advice.
HDFGS — Participation Finance Compliance
Loading…